Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1996;78:102-109

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sauvadet, A.
Right arrow Articles by Pavoine, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sauvadet, A.
Right arrow Articles by Pavoine, C.
(Circulation Research. 1996;78:102-109.)
© 1996 American Heart Association, Inc.


Articles

Synergistic Actions of Glucagon and Miniglucagon on Ca2+ Mobilization in Cardiac Cells

Anne Sauvadet, Troy Rohn, Françoise Pecker, Catherine Pavoine

From INSERM Unité 99, Hôpital Henri Mondor, Créteil, France.

Correspondence to Dr Catherine Pavoine, INSERM Unité 99, Hôpital Henri Mondor, 94010 Créteil, France.

Abstract It has been recently shown that the physiological processing of glucagon into its C-terminal (19-29) fragment, miniglucagon, by cardiac cells was essential for the contractile positive inotropic effect of the hormone. However, the mechanisms underlying the effects of miniglucagon remained undetermined. In the present study, we assessed the effects of miniglucagon on Ca2+ homeostasis in embryonic chick ventricular myocytes. In quiescent cells, short-term applications of 0.1 nmol/L miniglucagon markedly increased the accumulation of 45Ca into intracellular compartments resistant to digitonin lysis and sensitive to caffeine. Ca2+ accumulation into the sarcoplasmic reticular (SR) store was further attested by fura 2 imaging studies on quiescent or prestimulated cells: miniglucagon potentiated Ca2+ release from the SR compartment triggered by caffeine and evoked a rise in cytosolic Ca2+ when applied on cells pretreated with 1 µmol/L thapsigargin, a specific inhibitor of the SR Ca2+ pump. Glucagon alone produced a small cytosolic Ca2+ signal that was considerably amplified by miniglucagon. The action of glucagon was mimicked by 8-bromo-cAMP and was blocked by isradipine, suggesting that it relied on the activation of L-type Ca2+ channels, via phosphorylation. We conclude that the combined actions of miniglucagon and glucagon on Ca2+ accumulation into SR stores and Ca2+ release from the same stores are likely to support the positive inotropic effect elicited in vivo by glucagon on heart contraction.


Key Words: glucagon • miniglucagon • cardiac cells • Ca2+




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. B. van Wezel, C. J. Zuurbier, E. de Jonge, E. W. C. M. van Dam, J. van Dijk, E. Endert, B. A. de Mol, and E. Fliers
Differential Effects of a Perioperative Hyperinsulinemic Normoglycemic Clamp on the Neurohumoral Stress Response during Coronary Artery Surgery
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4144 - 4153.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
D M Wood, K D Wright, A L Jones, and P I Dargan
Metaraminol (Aramine(R)) in the management of a significant amlodipine overdose
Human and Experimental Toxicology, July 1, 2005; 24(7): 377 - 381.
[Abstract] [PDF]


Home page
Journal of Pharmacy PracticeHome page
M. Hedge
Calcium Channel Blocker Toxicology
Journal of Pharmacy Practice, June 1, 2005; 18(3): 169 - 174.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
B. Ait-Mamar, M. Cailleret, C. Rucker-Martin, A. Bouabdallah, G. Candiani, C. Adamy, P. Duvaldestin, F. Pecker, N. Defer, and C. Pavoine
The Cytosolic Phospholipase A2 Pathway, a Safeguard of {beta}2-Adrenergic Cardiac Effects in Rat
J. Biol. Chem., May 13, 2005; 280(19): 18881 - 18890.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K Chang-Chretien, J T Chew, and D P Judge
Reversible dilated cardiomyopathy associated with glucagonoma
Heart, July 1, 2004; 90(7): e44 - e44.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Cailleret, A. Amadou, N. Andrieu-Abadie, A. Nawrocki, C. Adamy, B. Ait-Mamar, F. Rocaries, M. Best-Belpomme, T. Levade, C. Pavoine, et al.
N-Acetylcysteine Prevents the Deleterious Effect of Tumor Necrosis Factor-{alpha} on Calcium Transients and Contraction in Adult Rat Cardiomyocytes
Circulation, January 27, 2004; 109(3): 406 - 411.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Gros, X. You, L. L. Baggio, M. G. Kabir, A. M. Sadi, I. N. Mungrue, T. G. Parker, Q. Huang, D. J. Drucker, and M. Husain
Cardiac Function in Mice Lacking the Glucagon-Like Peptide-1 Receptor
Endocrinology, June 1, 2003; 144(6): 2242 - 2252.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Magne, D. Couchie, F. Pecker, and C. Pavoine
beta 2-Adrenergic Receptor Agonists Increase Intracellular Free Ca2+ Concentration Cycling in Ventricular Cardiomyocytes through p38 and p42/44 MAPK-mediated Cytosolic Phospholipase A2 Activation
J. Biol. Chem., October 19, 2001; 276(43): 39539 - 39548.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. A. Folliguet, C. Rucker-Martin, C. Pavoine, E. Deroubaix, M. Henaff, J.-J. Mercadier, and S. N. Hatem
Adult cardiac myocytes survive and remain excitable during long-term culture on synthetic supports
J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 510 - 519.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. Palmier, M. Vacher, S. Harbon, and D. Leiber
A Tyrosine Kinase Signaling Pathway, Regulated by Calcium Entry and Dissociated from Tyrosine Phosphorylation of Phospholipase Cgamma -1, Is Involved in Inositol Phosphate Production by Activated G Protein-Coupled Receptors in Myometrium
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 1022 - 1030.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Pavoine, S. Magne, A. Sauvadet, and F. Pecker
Evidence for a beta 2-Adrenergic/Arachidonic Acid Pathway in Ventricular Cardiomyocytes. REGULATION BY THE beta 1-ADRENERGIC/cAMP PATHWAY
J. Biol. Chem., January 8, 1999; 274(2): 628 - 637.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sauvadet, T. Rohn, F. Pecker, and C. Pavoine
Arachidonic Acid Drives Mini-glucagon Action in Cardiac Cells
J. Biol. Chem., May 9, 1997; 272(19): 12437 - 12445.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Amadou, A. Nawrocki, M. Best-Belpomme, C. Pavoine, and F. Pecker
Arachidonic acid mediates dual effect of TNF-alpha on Ca2+ transients and contraction of adult rat cardiomyocytes
Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1339 - C1347.
[Abstract] [Full Text] [PDF]